Utilizing the binding capacity of CRISPR/Cas9 to target the HIV-1 quasispecies
M. Nonnemacher,
W. Dampier,
M. Desimone,
V. Pirrone,
K. Kercher,
S. Passic,
J. Williams,
B. Wigdahl
Affiliations
M. Nonnemacher
Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, USA; Center for Molecular Virology and Translational Neuroscience, Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, PA, USA
W. Dampier
School of Biomedical Engineering and Health Systems, Drexel University, Philadelphia, PA, USA
M. Desimone
School of Biomedical Engineering and Health Systems, Drexel University, Philadelphia, PA, USA
V. Pirrone
Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, USA; Center for Molecular Virology and Translational Neuroscience, Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, PA, USA
K. Kercher
Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, USA; Center for Molecular Virology and Translational Neuroscience, Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, PA, USA
S. Passic
Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, USA; Center for Molecular Virology and Translational Neuroscience, Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, PA, USA
J. Williams
Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, USA; Center for Molecular Virology and Translational Neuroscience, Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, PA, USA
B. Wigdahl
Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, USA; Center for Molecular Virology and Translational Neuroscience, Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, PA, USA
